The Illume Difference

At Illume Mental Health, our approach to care is centered around the unique needs of each individual. We begin with 2-3 one hour evaluations. These evaluations are focused on thorough history taking where we will discuss your social context, genealogy, childhood, strengths, prior psychiatric history and current challenges. We will review any pertinent medical records you provide. The initial evaluation is a consultation, and is not a commitment to treatment.

At the end of the initial evaluation period we will provide a tailored treatment plan including a tentative formulation and specific recommendations for medications, psychotherapy, behavior change, further diagnostic evaluation, intensive care and or interventional psychiatry (TMS, ECT, ketamine).

What We Treat

We treat a variety of mental health conditions, including Depression, Anxiety, OCD, PTSD, cPTSD, ADHD, Bipolar Disorder, Personality Disorders and psychosis. Dr. Adelekun is an expert psychopharmacologist, with experience in management of Long Acting Injections, clozapine, and MAOIs.

Dr. Adelekun's approach to psychotherapy is relational and experiential. Through a combination of insight, capacity building and emotion processing, she works with her patients towards a richer life capable of holding both suffering and joy. Some people benefit from a different or more targeted psychotherapeutic approach, such as Cognitive Behavioral Therapy, Eye Movement Desensitization Reprocessing (EMDR), Exposure Response Prevention for OCD. This will be discussed during the initial evaluation and the appropriate referrals will be provided.

Our patients are active participants in their care. Whether engaged in medication management, psychotherapy or both; you will be asked to set specific goals for treatment, and monitor your progress towards those goals.

Dr. Adelekun

Dr. Adelekun is a first generation Nigerian immigrant and eldest daughter. She was raised in a small town in North Carolina. She completed her bachelors at Vanderbilt University where she studied Neuroscience and 'Medicine Health and Society'. She received her MD from Duke University School of Medicine where she graduated with a Deans Award and conducted research in mental health stigma. She took a year during her medical training to complete an MPH at Harvard University School of Public Health.

Dr. Adelekun completed her Residency training at UCLA Semel Institute for Neuroscience and Human Behavior, where she was both psychotherapy chief and psychosis clinic chief. Following graduation, she continued on faculty at UCLA teaching psychotherapy and working in various clinical environments including the Neuromodulation Department and UCLA's partial hospitalization program.